Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1036094 | 0.75 | — | — | |
| SCHEMBL1040019 | 0.73 | — | — | |
| SCHEMBL5029018 | 0.72 | — | — | |
| SCHEMBL16910902 | 0.70 | — | — | |
| SCHEMBL17313075 | 0.69 | — | — | |
| SCHEMBL2540102 | 0.69 | — | — | |
| SCHEMBL10911397 | 0.69 | — | — | |
| SCHEMBL20995934 | 0.69 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL29322980 | 0.69 | AKR1C3 (0.34) | — | |
| SCHEMBL2754726 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11926746-B2 | Active energy ray-curable ink and image recording method | FUJIFILM CORPORATION (JP) | 2024-03-12 | — | — | US | claimed |
| CN-114728520-B | Active energy ray-curable ink and image recording method | 富士胶片株式会社 | 2024-03-08 | — | — | CN | claimed |
| US-11555081-B2 | Multifunctional bisacylphosphine oxide photoinitiators | IGM RESINS ITALIA S.R.L. (IT) | 2023-01-17 | — | — | US | claimed |
| EP-4059719-A1 | ACTIVE ENERGY BEAM-CURABLE INK AND IMAGE RECORDING METHOD | FUJIFILM Corporation (JP) | 2022-09-21 | — | — | EP | claimed |
| US-20210347919-A1 | MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS | IGM RESINS ITALIA S.R.L. (IT) | 2021-11-11 | — | — | US | claimed |
| EP-3847179-A1 | MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS | IGM Resins Italia S.r.l. (IT) | 2021-07-14 | — | — | EP | claimed |
| WO-2021095580-A1 | ACTIVE ENERGY BEAM-CURABLE INK AND IMAGE RECORDING METHOD | 富士フイルム株式会社 | 2021-05-20 | — | — | WO | claimed |
| CN-112673012-A | Multifunctional bisacylphosphine oxide photoinitiators | 意大利艾坚蒙树脂有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-107001400-B | Multifunctional acylphosphine oxide photoinitiator | 意大利艾坚蒙树脂有限公司 | 2019-08-27 | — | — | CN | claimed |
| EP-3149013-B1 | MULTIFUNCTIONAL ACYLPHOSPHINE OXIDE PHOTOINITIATORS | IGM RESINS ITALIA SRL (IT) | 2018-10-24 | — | — | EP | claimed |
| US-10106629-B2 | Multifunctional acylphosphine oxide photoinitiators | IGM RESINS ITALIA S.R.L. (IT) | 2018-10-23 | — | — | US | claimed |
| US-20170240659-A1 | Multifunctional acylphosphine oxide photoinitiators | IGM RESINS ITALIA S.R.L. (IT) | 2017-08-24 | — | — | US | claimed |
| EP-3149013-A1 | MULTIFUNCTIONAL ACYLPHOSPHINE OXIDE PHOTOINITIATORS | IGM Resins Italia S.r.l. (IT) | 2017-04-05 | — | — | EP | claimed |
| WO-2015181332-A1 | MULTIFUNCTIONAL ACYLPHOSPHINE OXIDE PHOTOINITIATORS | IGM RESINS ITALIA S.R.L. (IT) | 2015-12-03 | — | — | WO | claimed |
| EP-1476452-B1 | ACYL- AND BISACYLPHOSPHINE DERIVATIVES | BASF SE (DE) | 2011-07-20 | — | — | EP | claimed |
| US-7511084-B2 | Acyl- and bisacylphosphine derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-31 | — | — | US | claimed |
| US-20050222294-A1 | Acyl- and bisacylphosphine derivatives | IGM GROUP B.V. (NL) | 2005-10-06 | — | — | US | claimed |
| CN-112673012-B | Multifunctional bisacylphosphine oxide photoinitiator | 意大利艾坚蒙树脂有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20040116702-A1 | Alkoxylated acyl-and bisacylphoshine derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-17 | — | — | US | disclosed |
| WO-2003068785-A1 | MONO- AND BIACYLPHOSPHINE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11555081-B2 | Multifunctional bisacylphosphine oxide photoinitiators | PHOSPHO1, AGPAT5, PARG | ALDH1A1 2367/4885SMN1; SMN2 4468/4885 |
| US-20210347919-A1 | MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS | PHOSPHO1, AGPAT5, PARG | ALDH1A1 2367/4885SMN1; SMN2 4468/4885 |
| US-10106629-B2 | Multifunctional acylphosphine oxide photoinitiators | PHOSPHO1, AGPAT5, AGPAT2 | ALDH1A1 2338/4885SMN1; SMN2 4487/4885 |
| US-20170240659-A1 | Multifunctional acylphosphine oxide photoinitiators | PHOSPHO1, AGPAT5, AGPAT2 | ALDH1A1 2338/4885SMN1; SMN2 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.